NASCIMBENI, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.442
EU - Europa 2.377
AS - Asia 858
SA - Sud America 18
AF - Africa 14
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.720
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.422
GB - Regno Unito 766
IT - Italia 622
SE - Svezia 322
SG - Singapore 279
CN - Cina 275
DE - Germania 216
HK - Hong Kong 131
UA - Ucraina 89
FR - Francia 71
FI - Finlandia 70
TR - Turchia 69
BG - Bulgaria 65
IN - India 31
LT - Lituania 24
BE - Belgio 22
ID - Indonesia 20
RO - Romania 18
CA - Canada 17
RU - Federazione Russa 17
VN - Vietnam 17
IE - Irlanda 15
CH - Svizzera 13
BR - Brasile 12
NL - Olanda 10
ES - Italia 9
CZ - Repubblica Ceca 8
AU - Australia 7
MY - Malesia 7
KR - Corea 6
MK - Macedonia 6
EG - Egitto 5
IR - Iran 5
PH - Filippine 5
PE - Perù 3
PK - Pakistan 3
SI - Slovenia 3
TW - Taiwan 3
ZA - Sudafrica 3
AT - Austria 2
BZ - Belize 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
JP - Giappone 2
NG - Nigeria 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BF - Burkina Faso 1
CL - Cile 1
CU - Cuba 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
HU - Ungheria 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
Totale 9.720
Salva come PNG Salva come JPEG
Città #
Fairfield 1.096
Southend 620
Woodbridge 557
Ashburn 509
Chandler 470
Seattle 440
Houston 434
Wilmington 397
Santa Clara 359
Cambridge 347
Ann Arbor 317
Nyköping 269
Dearborn 236
Singapore 223
Hong Kong 128
Jacksonville 117
Modena 103
San Diego 79
Beijing 76
New York 75
Princeton 64
Sofia 63
Eugene 62
Izmir 53
Helsinki 51
London 30
Shanghai 30
Rome 29
Bremen 26
Milan 26
Redwood City 24
Fremont 22
Brussels 20
Jakarta 20
San Mateo 17
Dong Ket 16
Falls Church 15
Timisoara 15
Norwalk 14
Boardman 12
Dublin 12
Munich 12
Palermo 12
Nanjing 11
Padova 11
Parma 11
Reggio Emilia 11
Naples 10
Abbiategrasso 9
Bologna 9
Kilburn 9
Toronto 9
Chicago 8
Hefei 8
Turin 8
Bari 7
Brno 7
Dallas 7
Jinan 7
Verona 7
Augusta 6
Des Moines 6
Grafing 6
Guangzhou 6
Kunming 6
Messina 6
Paris 6
Brescia 5
Chiswick 5
Frankfurt am Main 5
Fuzhou 5
Hounslow 5
Perugia 5
Phoenix 5
San Jose 5
Bobbio 4
Cagliari 4
Hebei 4
Lausanne 4
Leawood 4
Los Angeles 4
Misterbianco 4
Monmouth Junction 4
Nanchang 4
Osimo 4
Philadelphia 4
Ravenna 4
São Paulo 4
Trieste 4
Atessa 3
Basel 3
Cepagatti 3
Fiesole 3
Florence 3
Johannesburg 3
Lima 3
Montesilvano Marina 3
Mumbai 3
Nanning 3
Napoli 3
Totale 7.817
Salva come PNG Salva come JPEG
Nome #
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 484
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 390
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 225
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 223
Drugs and acute porphyrias: reasons for a hazardous relationship 213
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 200
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 196
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 193
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 187
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 186
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 185
A critical appraisal of the use of ultrasound in hepatic steatosis 181
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes 178
Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy 176
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 176
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 175
Nonalcoholic fatty liver disease: Evolving paradigms 175
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease 174
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 173
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease 172
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. 162
From NAFLD in clinical practice to answers from guidelines. 160
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 160
Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm? 160
Role of Multidrug-Resistance Protein 2 in coproporphyrin transport: results from experimental studies in bile fistula rat models 158
Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease 158
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 151
Hypothyroidism and nonalcoholic fatty liver disease - A chance association? 150
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 149
Clinical, biochemical and genetic characteristics of Variegate Porphyria in Italy 148
Alcohol and Steatosis: The Japanese Paradox 148
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? 143
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 142
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 137
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 137
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 135
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease 135
Insulin resistance in advanced liver cirrhosis : the role of liver dysfunction and the “dissociated” effect on glucose versus lipid and amino acid metabolism 134
Telomere shortening: An innocent bystander at the crossroad of NASH with ageing and cardiometabolic risk? 131
Clinical relevance of liver histopathology and different histological classifications of NASH in adults 130
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease 130
Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: Chance tetrad or association by necessity? 129
Association between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis 128
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? 124
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease 124
NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk 123
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 122
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 121
Sex Differences in NAFLD: State of the Art and Identification of Research Gaps 119
Hyperferritinemia and diagnosis of type 1 Gaucher disease 119
Looking for women in hepatology: Sex authorship differences in clinical practice guidelines and position statements 114
Association of nonalcoholic fatty liver disease (Nafld) with peripheral diabetic polyneuropathy: A systematic review and meta-analysis 113
Is it time to include non-alcoholic fatty liver disease in the current risk scores for atrial fibrillation? 109
Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity? 108
Non-alcoholic fatty liver disease: Diagnosis and investigation 105
The genetic basis of Insulin resistance. A brief review 103
Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomeres involvement on line pubblication 03-Oct-2012Hepatology- 99
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 94
Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases 90
Hepatic and extrahepatic malignancies in NAFLD 90
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist 86
A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect? 79
Global multi-stakeholder endorsement of the MAFLD definition 71
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction 51
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 29
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 28
Colon cancer in a 12-year-old girl with hypertriglyceridemia 17
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 13
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group 12
Totale 9.840
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.262
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.778 0 0 0 0 190 381 401 266 250 105 123 62
2020/20211.961 176 80 166 161 215 162 238 202 120 182 164 95
2021/20221.311 97 117 61 77 83 112 43 47 162 143 244 125
2022/20231.412 132 173 139 122 151 180 28 148 176 17 66 80
2023/2024846 34 54 81 71 164 76 59 85 22 22 58 120
2024/2025823 82 47 100 194 400 0 0 0 0 0 0 0
Totale 9.840